2007
Imaging the Neurochemistry of Alcohol and Substance Abuse
Martinez D, Kim JH, Krystal J, Abi-Dargham A. Imaging the Neurochemistry of Alcohol and Substance Abuse. Neuroimaging Clinics Of North America 2007, 17: 539-555. PMID: 17983969, DOI: 10.1016/j.nic.2007.07.004.Peer-Reviewed Original ResearchNeural Synchrony in Schizophrenia: From Networks to New Treatments
Ford JM, Krystal JH, Mathalon DH. Neural Synchrony in Schizophrenia: From Networks to New Treatments. Schizophrenia Bulletin 2007, 33: 848-852. PMID: 17567628, PMCID: PMC2632315, DOI: 10.1093/schbul/sbm062.Peer-Reviewed Original ResearchConceptsBrain regionsNeural basisFunctional neuroanatomyNeural oscillationsTemporal synchronyNeural synchronyDifferent brain regionsNeural activityNeural assembliesNeural populationsCognitive dysfunctionDistinct neuronal populationsSchizophreniaTemporal domainPhasic relationshipSynaptic transmissionNeuronal populationsTranslational studiesNew treatmentsEmergent propertiesSynchronyNeural networkNeuroanatomyPsychosisNeurochemistry
2006
MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases
Mason GF, Krystal JH. MR spectroscopy: its potential role for drug development for the treatment of psychiatric diseases. NMR In Biomedicine 2006, 19: 690-701. PMID: 16986118, DOI: 10.1002/nbm.1080.Peer-Reviewed Original ResearchConceptsPsychiatric diseasesMagnetic resonance spectroscopyGlial abnormalitiesPsychiatric disordersBiochemical markersNon-invasive techniqueNeuropsychiatric disordersPotential roleDrug developmentDrug discoveryMRS techniquesDiseaseDisordersStudy of mechanismsTreatmentLines of investigationAbnormalitiesNeurochemistryDrug delivery
2003
The Neurochemistry of Schizophrenia
Moghaddam B, Krystal J. The Neurochemistry of Schizophrenia. 2003, 349-364. DOI: 10.1002/9780470987353.ch19.Peer-Reviewed Original Research